Results 211 to 220 of about 2,254,142 (303)
Abstract Bio‐based ethyl lactate (EL) can replace several fossil‐derived products owing to its low toxicity, high solvent functionality, and environmental advantages. This study assesses the techno‐economic viability and greenhouse gas (GHG) reduction potential of producing EL from sugarcane A‐molasses and lignocelluloses in an energy self‐sufficient ...
Motshamonyane J. Phasha +2 more
wiley +1 more source
Sci-Tech finance efficiency promotes the construction of a modernized industrial system evidence from double machine learning. [PDF]
Huang R +5 more
europepmc +1 more source
Abstract The study identified process development priorities toward the feasible production of five value‐added biochemicals in a sugarcane biorefinery based on achievable bioconversion performances. Multiple process scenarios using A‐molasses as feedstock were simulated in Aspen Plus® via direct microbial conversions.
Manasseh K. Sikazwe +2 more
wiley +1 more source
Study on the relationship between buyer market power, spatial spillover effect, and profit in China's pharmaceutical industry. [PDF]
Guanyi Y, Lei W, Heng C, Zhengliang D.
europepmc +1 more source
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree +2 more
wiley +1 more source
Assessing the impact of government healthcare expenditure and life expectancy on economic growth in Saudi Arabia: an econometric time-series study (2000-2023). [PDF]
Alghannam R, Alharbi A.
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Can government-guided funds promote innovation output in strategic emerging enterprises? Evidence from China. [PDF]
Zhao C, Zhang L.
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source

